Abstract:Lacking an effective mechanism to safely and consistently enhance macromolecular uptake across the intestinal epithelium, prospects for successful development of oral therapeutic peptide drugs remain unlikely. We previously addressed this challenge by identifying an endogenous mechanism that controls intestinal paracellular permeability that can be activated by a peptide, termed PIP 640, which can increase cellular levels of phosphorylated myosin light chain at position S19 (MLC-pS19). Apical application in vitro or luminal application in vivo was shown to increase macromolecular solute transport within minutes that recovered completely within a few hours after removal. We now examine the nature of PIP 640-mediated permeability changes. Confluent Caco-2 cell monolayers treated with PIP 640 enhanced apical-to-basolateral (AB) transport of 4-kDa, but not 10-kDa, dextran. Expression and/or cellular distribution changes of tight junction (TJ) proteins were restricted to increased claudin-2 over a time course that correlated with an apparent shift in its distribution from the nucleus to the membrane fraction of the cell. PIP 640-mediated epithelial changes were distinct from the combined actions of the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-α) and interferon gamma (IFN-γ). While TNF-α/IFN-γ treatment also increased MLC-pS19 levels, these cytokines enhanced AB transport for 70-kDa dextran and decreased occludin expression at TJs. Claudin-2-dependent changes induced by PIP 640 resulted in an AB transport bias for positively-charged macromolecules demonstrated in vitro using charge variants of 4-kDa dextrans and by comparing transport of salmon calcitonin to exenatide. Comparable outcomes of increased TJ localization of claudin-2 and enhanced transport of these therapeutic peptides that biased toward cationic characteristics was demonstrated in vivo following after intra-luminal injection into rat jejunum. Together, these data have shown a potential mechanism for PIP 640 to enhance paracellular permeability of solutes in the size range of small therapeutic peptides that is biased toward positively-charged solutes.

Transepithelial Transport of Milk-Derived Angiotensin I-converting Enzyme Inhibitory Peptide with the RLSFNP Sequence.

Transepithelial Transport Route and Liposome Encapsulation of Milk-Derived ACE-Inhibitory Peptide Arg-Leu-Ser-Phe-Asn-Pro.

Transport of Antihypertensive Peptide RVPSL, Ovotransferrin 328-332, in Human Intestinal Caco-2 Cell Monolayers.

Transport of Soybean Protein-Derived Antihypertensive Peptide LSW Across Caco-2 Monolayers

Intestinal Absorption of Milk-Derived ACE Inhibitory Peptides LL and LPEW Using Caco-2 Cell Model

Transport of Val-Leu-Pro-Val-Pro in human intestinal epithelial (Caco-2) cell monolayers.

Hydrolysis and Transepithelial Transport of Two Corn Gluten Derived Bioactive Peptides in Human Caco-2 Cell Monolayers

Transport Study of Egg-Derived Antihypertensive Peptides (LKP and IQW) Using Caco-2 and HT29 Coculture Monolayers.

Antihypertensive Effect In Vivo Of Qaglspvr And Its Transepithelial Transport Through The Caco-2 Cell Monolayer

Rhamnolipids Enhance Epithelial Permeability in Caco-2 Monolayers.

Hydrolysis and Transport of Egg White-Derived Peptides in Caco-2 Cell Monolayers and Everted Rat Sacs.

Production and Transepithelial Transportation of Angiotensin-I-converting Enzyme (Ace)-Inhibitory Peptides from Whey Protein Hydrolyzed by Immobilized Lactobacillus Helveticus Proteinase.

Transport behavior and efflux of Rg1 in rat pulmonary epithelial cells.

Transport, In Vivo Antihypertensive Effect, and Pharmacokinetics of an Angiotensin-Converting Enzyme (ACE) Inhibitory Peptide LVLPGE

Transport of Leuprolide Across Rat Intestine, Rabbit Intestine and Caco-2 Cell Monolayer

Transepithelial transport mechanisms of 7,8-dihydroxyflavone, a small molecular TrkB receptor agonist, in human intestinal Caco-2 cells.

Transepithelial Transport Characteristics of the Cholesterol- Lowing Soybean Peptide, WGAPSL, in Caco-2 Cell Monolayers

Angiotensin I-converting Enzyme-Inhibitory Peptides from Bovine Collagen: Insights into Inhibitory Mechanism and Transepithelial Transport.

An intestinal paracellular pathway biased toward positively-charged macromolecules

Angiopep-2-functionalized nanoparticles enhance transport of protein drugs across intestinal epithelia by self-regulation of targeted receptors.

Production And Transepithelial Transportation Of Casein-Derived Peptides And Identification A Novel Antioxidant Peptide Lhsmk